MMWRBooster -

MMWR Booster for: Progress Toward Measles and Rubella Elimination — India, 2005–2021, Weekly / December 16, 2022 / 71(50);1569–1575

Posted on January 4, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways Increased Vaccine Coverage: From 2005 to 2021, coverage with the first dose of a measles-containing vaccine (MCV) increased from 68% to 89%, and the second dose from

MMWR Booster for: Notes from the Field: Clinical and Epidemiologic Characteristics of Mpox Cases from the Initial Phase of the Outbreak — New York City, May 19–July 15, 2022, Weekly / December 30, 2022 / 71(5152);1631–1633

Posted on January 3, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Demographics and Risk Behaviors: Among 719 mpox patients in NYC, 97.9% were men, predominantly identifying as gay or queer (78.7%), or bisexual (5.6%). A significant proportion reported

MMWR Booster for: Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022, Weekly / December 30, 2022 / 71(5152);1616–1624

Posted on January 3, 2024 by Cody Micah Carmichael MPH, CPH

Top 5 Takeaways: Bivalent mRNA Vaccine Effectiveness: The study found that bivalent mRNA vaccines are effective in preventing COVID-19–associated emergency department/urgent care encounters and hospitalizations among immunocompetent adults. Comparative Analysis:

Epidemiology, Broadly Speaking

Tag: MMWRBooster